Secretory pathway quality control operating in Golgi, plasmalemmal, and endosomal systems

被引:161
作者
Arvan, P
Zhao, X
Ramos-Castaneda, J
Chang, A
机构
[1] Albert Einstein Coll Med, Div Endocrinol, Ctr Diabet, Bronx, NY 10461 USA
[2] Albert Einstein Coll Med, Dept Dev Mol Biol, Bronx, NY 10461 USA
[3] Albert Einstein Coll Med, Dept Anat Struct Biol, Bronx, NY 10461 USA
关键词
degradation; multivesicular endosome; proteasome; ubiquitylation; vps genes;
D O I
10.1034/j.1600-0854.2002.31102.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Exportable proteins that have significant defects in nascent polypeptide folding or subunit assembly are frequently retained in the endoplasmic reticulum and subject to endoplasmic reticulum-associated degradation by the ubiquitin-proteasome system. In addition to this, however, there is growing evidence for post-endoplasmic reticulum quality control mechanisms in which mutant or non-native exportable proteins may undergo anterograde transport to the Golgi complex and post-Golgi compartments before intracellular disposal. In some instances, these proteins may undergo retrograde transport back to the endoplasmic reticulum with re-targeting to the endoplasmic reticulum-associated degradation pathway; in other typical cases, they are targeted into the endosomal system for degradation by vacuolar/lysosomal proteases. Such quality control targeting is likely to involve recognition of features more commonly expressed in mutant proteins, but may also be expressed by wild-type proteins, especially in cells with perturbation of local environments that are essential for normal protein trafficking and stability in the secretory pathway and at the cell surface .
引用
收藏
页码:771 / 780
页数:10
相关论文
共 95 条